Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction

Merry L. Lindsey, Michael E. Hall, Romain Harmancey, Yonggang Ma

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Following myocardial infarction (MI), the left ventricle (LV) undergoes a series of cardiac wound healing responses that involve stimulation of robust inflammation to clear necrotic myocytes and tissue debris and induction of extracellular matrix (ECM) protein synthesis to generate a scar. Proteomic strategies provide us with a means to index the ECM proteins expressed in the LV, quantify amounts, determine functions, and explore interactions. This review will focus on the efforts taken in the proteomics research field that have expanded our understanding of post-MI LV remodeling, concentrating on the strengths and limitations of different proteomic approaches to glean information that is specific to ECM turnover in the post-MI setting. We will discuss how recent advances in sample preparation and labeling protocols increase our successes at detecting components of the cardiac ECM proteome. We will summarize how proteomic approaches, focusing on the ECM compartment, have progressed over time to current gel-free methods using decellularized fractions or labeling strategies that will be useful for clinical applications. This review will provide an overview of how cardiac ECM proteomics has evolved over the last decade and will provide insight into future directions that will drive forward our understanding of cardiac ECM turnover in the post-MI LV.

Original languageEnglish (US)
Article number19
JournalClinical Proteomics
Volume13
Issue number1
DOIs
StatePublished - Sep 15 2016

Fingerprint

Proteomics
Extracellular Matrix
Myocardial Infarction
Heart Ventricles
Extracellular Matrix Proteins
Labeling
Ventricular Remodeling
Proteome
Debris
Wound Healing
Muscle Cells
Cicatrix
Gels
Clinical Studies
Tissue
Inflammation
Research

Keywords

  • Glycoproteomics
  • Left ventricle
  • Matridomics
  • Matrikine
  • Matrix metalloproteinase
  • Population scale proteomics
  • Secretomics

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction. / Lindsey, Merry L.; Hall, Michael E.; Harmancey, Romain; Ma, Yonggang.

In: Clinical Proteomics, Vol. 13, No. 1, 19, 15.09.2016.

Research output: Contribution to journalReview article

@article{48ec3902228846bf923b270019eff312,
title = "Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction",
abstract = "Following myocardial infarction (MI), the left ventricle (LV) undergoes a series of cardiac wound healing responses that involve stimulation of robust inflammation to clear necrotic myocytes and tissue debris and induction of extracellular matrix (ECM) protein synthesis to generate a scar. Proteomic strategies provide us with a means to index the ECM proteins expressed in the LV, quantify amounts, determine functions, and explore interactions. This review will focus on the efforts taken in the proteomics research field that have expanded our understanding of post-MI LV remodeling, concentrating on the strengths and limitations of different proteomic approaches to glean information that is specific to ECM turnover in the post-MI setting. We will discuss how recent advances in sample preparation and labeling protocols increase our successes at detecting components of the cardiac ECM proteome. We will summarize how proteomic approaches, focusing on the ECM compartment, have progressed over time to current gel-free methods using decellularized fractions or labeling strategies that will be useful for clinical applications. This review will provide an overview of how cardiac ECM proteomics has evolved over the last decade and will provide insight into future directions that will drive forward our understanding of cardiac ECM turnover in the post-MI LV.",
keywords = "Glycoproteomics, Left ventricle, Matridomics, Matrikine, Matrix metalloproteinase, Population scale proteomics, Secretomics",
author = "Lindsey, {Merry L.} and Hall, {Michael E.} and Romain Harmancey and Yonggang Ma",
year = "2016",
month = "9",
day = "15",
doi = "10.1186/s12014-016-9120-2",
language = "English (US)",
volume = "13",
journal = "Clinical Proteomics",
issn = "1542-6416",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction

AU - Lindsey, Merry L.

AU - Hall, Michael E.

AU - Harmancey, Romain

AU - Ma, Yonggang

PY - 2016/9/15

Y1 - 2016/9/15

N2 - Following myocardial infarction (MI), the left ventricle (LV) undergoes a series of cardiac wound healing responses that involve stimulation of robust inflammation to clear necrotic myocytes and tissue debris and induction of extracellular matrix (ECM) protein synthesis to generate a scar. Proteomic strategies provide us with a means to index the ECM proteins expressed in the LV, quantify amounts, determine functions, and explore interactions. This review will focus on the efforts taken in the proteomics research field that have expanded our understanding of post-MI LV remodeling, concentrating on the strengths and limitations of different proteomic approaches to glean information that is specific to ECM turnover in the post-MI setting. We will discuss how recent advances in sample preparation and labeling protocols increase our successes at detecting components of the cardiac ECM proteome. We will summarize how proteomic approaches, focusing on the ECM compartment, have progressed over time to current gel-free methods using decellularized fractions or labeling strategies that will be useful for clinical applications. This review will provide an overview of how cardiac ECM proteomics has evolved over the last decade and will provide insight into future directions that will drive forward our understanding of cardiac ECM turnover in the post-MI LV.

AB - Following myocardial infarction (MI), the left ventricle (LV) undergoes a series of cardiac wound healing responses that involve stimulation of robust inflammation to clear necrotic myocytes and tissue debris and induction of extracellular matrix (ECM) protein synthesis to generate a scar. Proteomic strategies provide us with a means to index the ECM proteins expressed in the LV, quantify amounts, determine functions, and explore interactions. This review will focus on the efforts taken in the proteomics research field that have expanded our understanding of post-MI LV remodeling, concentrating on the strengths and limitations of different proteomic approaches to glean information that is specific to ECM turnover in the post-MI setting. We will discuss how recent advances in sample preparation and labeling protocols increase our successes at detecting components of the cardiac ECM proteome. We will summarize how proteomic approaches, focusing on the ECM compartment, have progressed over time to current gel-free methods using decellularized fractions or labeling strategies that will be useful for clinical applications. This review will provide an overview of how cardiac ECM proteomics has evolved over the last decade and will provide insight into future directions that will drive forward our understanding of cardiac ECM turnover in the post-MI LV.

KW - Glycoproteomics

KW - Left ventricle

KW - Matridomics

KW - Matrikine

KW - Matrix metalloproteinase

KW - Population scale proteomics

KW - Secretomics

UR - http://www.scopus.com/inward/record.url?scp=84987755481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987755481&partnerID=8YFLogxK

U2 - 10.1186/s12014-016-9120-2

DO - 10.1186/s12014-016-9120-2

M3 - Review article

C2 - 27651752

AN - SCOPUS:84987755481

VL - 13

JO - Clinical Proteomics

JF - Clinical Proteomics

SN - 1542-6416

IS - 1

M1 - 19

ER -